1-20 of 45
Min Zhou
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy and safety of rocbrutinib, a highly selective 4th-generation Bruton's tyrosine kinase inhibitor, in relapsed/refractory Mantle Cell Lymphoma (R/R MCL): Updated results from the phase 1 study

Free
Yuqin Song, Qingqing Cai, Keshu Zhou, Zhengming Jin, Ming Jiang, Xiuhua Sun, Lei Zhang, Haiyan Yang, Lanfang Li, Kaiyang Ding, Junyuan Qi, MIN Zhou, Hongmei Jing, Wei Yang, Hui Zhou, Jun Ma, Zhigang Peng, Wei Xu, Yuankai Shi, Guohui Cui, Zheng Wang, Nawei Liu, Yejiang Lou, Yue Shen, Yi Chen, Fenlai Tan, Jun Zhu
Journal: Blood
Blood (2025) 146 (Supplement 1): 3587.
https://doi.org/10.1182/blood-2025-3587
Published: 2025
Journal Articles

Prognostic significance of pulmonary involvement in idiopathic multicentric castleman disease

Free
Yu-han Gao, Jia-min Zhou, Cong-Wei Jia, Siyuan Li, Yue Dang, Lu Zhang, Jian Li
Journal: Blood
Blood (2025) 146 (Supplement 1): 1229.
https://doi.org/10.1182/blood-2025-1229
Published: 2025
Journal Articles

Efficacy and safety of a fully human BCMA CAR T-cell therapy for high-risk newly diagnosed transplant-ineligible multiple myeloma: Updated results from an open label, single-arm，phase 1 study（fumanba-2）

Free
Bing Chen, Xiaoyan Shao, Yuanyuan Jin, Yong Xu, Qinglin Shi, Chaoyang Guan, Xuxing Shen, Ping Li, Yujie Wu, Hui Zeng, Yu Zhu, Min Zhou, Lei Fan, Yaqiong Lu, Hongyu Gui, Lijuan Chen
Journal: Blood
Blood (2025) 146 (Supplement 1): 254.
https://doi.org/10.1182/blood-2025-254
Published: 2025
Journal Articles

Efficacy and safety of rocbrutinib, a highly selective 4th-generation BTK inhibitor, in Chinese patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)

Free
Yuqin Song, Qingqing Cai, Keshu Zhou, Zhengming Jin, Ming Jiang, Xiuhua Sun, Lei Zhang, Haiyan Yang, Lanfang Li, Kaiyang Ding, Junyuan Qi, MIN Zhou, Hongmei Jing, Wei Yang, Hui Zhou, Jun Ma, Zhigang Peng, Wei Xu, Li Yu, Yuankai Shi, Guohui Cui, Zheng Wang, Nawei Liu, Yejiang Lou, Yue Shen, Yi Chen, Fenlai Tan, Jun Zhu
Journal: Blood
Blood (2025) 146 (Supplement 1): 3896.
https://doi.org/10.1182/blood-2025-3896
Published: 2025
Journal Articles

PRKRA associated with NF-κB activation in pulmonary involvement of idiopathic multicentric castleman disease

Free
Yu-han Gao, Cong-Wei Jia, Zhi-yuan Li, Jia-min Zhou, Zhen-huan Tian, Siyuan Li, Yue Dang, Lu Zhang, Jian Li
Journal: Blood
Blood (2025) 146 (Supplement 1): 4784.
https://doi.org/10.1182/blood-2025-4784
Published: 2025
Journal Articles

Blinatumomab following reduced-intensity induction chemotherapy in Chinese children with intermediate- or high-risk B-cell precursor acute lymphoblastic leukemia

Free
Ruidong Zhang, Lihua Yang, Wei Liu, Hua Jiang, Yunpeng Dai, Yue Wang, Li Wang, Yufeng Liu, Rong Liu, Xin Tian, Ansheng Liu, Yanling Tao, Baoxi Zhang, Hui Liang, Rui Yang, Sen Chen, Lijun Qu, Min Zhou, Xiaoling Liang, Yanli Cheng, Yueqin Han, Hao Xiong, Yan Liu, Gang Xu, Peijing Qi, Tianyou Wang
Journal: Blood
Blood (2025) 146 (Supplement 1): 5133.
https://doi.org/10.1182/blood-2025-5133
Published: 2025
Journal Articles

Efficacy and safety of hetrombopag, a novel thrombopoietin receptor agonist, in children and adolescents with immune thrombocytopenia: Results from a randomized, multicenter, placebo-controlled phase 3 trial

Free
Runhui Wu, Ju Gao, Yufeng Liu, Jie Yu, Shaoyan Hu, Hui Liang, Hui Jiang, Xiaowen Zhai, Min Zhou, Wenge Hao, Heng Mei, Fei Li, Yumei Chen, Wei Liu, Mei Yan, Runzi Li, Junye Xiong, Zhenyi Zhu, Tianyou Wang
Journal: Blood
Blood (2025) 146 (Supplement 1): 4804.
https://doi.org/10.1182/blood-2025-4804
Published: 2025
Journal Articles

Real-world effectiveness and safety of belumosudil in pediatric chronic graft-versus-host disease: A retrospective cohort study

Free
Min Zhou, Jun Lu, Peifang Xiao, Yixin Hu, Jiajia Zheng, Li Gao, Ailian Guo, Liyan Fan, Jie Li, Yanhua Yao, Shaoyan Hu
Journal: Blood
Blood (2025) 146 (Supplement 1): 6026.
https://doi.org/10.1182/blood-2025-6026
Published: 2025
Journal Articles

N-homocysteinylation of β-arrestins biases GPCR signaling and promotes platelet activation

Available to Purchase
Lin-Qi Zhang, Chang-Xiao Che, Ya-Qin Du, Lu-Lu Han, Jia-Le Wang, Chen-Yu Zhang, Shen-Ming Huang, Zhong-Yuan Zheng, Qing-Tao He, Zhao Yang, Long Zhang, Nan Chen, Fan Yang, Ying-Li Jia, Shi-Min Zhao, De-Min Zhou, Chu Wang, Xian Wang, Jin-Peng Sun, Lu Tie
Journal: Blood
Blood (2025) 145 (20): 2374–2389.
https://doi.org/10.1182/blood.2024025593
Published: 2025
Includes: Supplemental data
Journal Articles

Safety and Efficacy of Rocbrutinib in Patients with Relapsed/Refractory Marginal Zone Lymphoma

Free
Yuqin Song, Qingqing Cai, Keshu Zhou, Ming Jiang, Zhengming Jin, Lei Zhang, Xiuhua Sun, Haiyan Yang, Lanfang Li, Kaiyang Ding, Junyuan Qi, Hongmei Jing, Wei Yang, Min Zhou, Jun Ma, Zhigang Peng, Wei Xu, Hui Zhou, Li Yu, Yuankai Shi, Guohui Cui, Zheng Wang, Nawei Liu, Yejiang Lou, Yue Shen, Yi Chen, Fenlai Tan, Jun Zhu
Journal: Blood
Blood (2024) 144 (Supplement 1): 1635.
https://doi.org/10.1182/blood-2024-194572
Published: 2024
Journal Articles

Rocbrutinib, a New-Generation BTK Inhibitor, Demonstrates Safety and Efficacy in Relapsed/Refractory Non-GCB Diffuse Large B Cell Lymphoma

Free
Yuqin Song, Qingqing Cai, Keshu Zhou, Ming Jiang, Zhengming Jin, Lei Zhang, Xiuhua Sun, Haiyan Yang, Lanfang Li, Kaiyang Ding, Junyuan Qi, Hongmei Jing, Wei Yang, Min Zhou, Jun Ma, Zhigang Peng, Wei Xu, Hui Zhou, Li Yu, Yuankai Shi, Guohui Cui, Zheng Wang, Nawei Liu, Yejiang Lou, Yue Shen, Yi Chen, Fenlai Tan, Jun Zhu
Journal: Blood
Blood (2024) 144 (Supplement 1): 3119.
https://doi.org/10.1182/blood-2024-194561
Published: 2024
Journal Articles

Safety and Efficacy Results from the Phase I Study of a Novel Dual Covalent and Non-Covalent Next Generation Inhibitor of Bruton's Tyrosine Kinase LP-168 in Patients with Relapsed/Refractory Mantle Cell Lymphoma

Free
Yuqin Song, Qingqing Cai, Ming Jiang, Keshu Zhou, Lei Zhang, Xiuhua Sun, Zhengming Jin, Lanfang Li, Hongmei Jing, Zhigang Peng, Haiyan Yang, Junyuan Qi, Hui Zhou, Wei Yang, Min Zhou, Chunyan Ji, Wei Xu, Kaiyang Ding, Li Yu, Zheng Wang, Nawei Liu, Yejiang Lou, Yue Shen, Yi Chen, Fenlai Tan, Jun Zhu
Journal: Blood
Blood (2023) 142 (Supplement 1): 3033.
https://doi.org/10.1182/blood-2023-180694
Published: 2023
Journal Articles

A Novel Dual Covalent and Non-Covalent Next Generation Inhibitor of Bruton's Tyrosine Kinase LP-168 in Patients with Relapsed/Refractory B Cell Non-Hodgkin Lymphoma: Safety and Efficacy Results from a Phase 1 Study

Free
Yuqin Song, Qingqing Cai, Ming Jiang, Keshu Zhou, Lei Zhang, Xiuhua Sun, Zhengming Jin, Lanfang Li, Hongmei Jing, Zhigang Peng, Haiyan Yang, Junyuan Qi, Hui Zhou, Wei Yang, Min Zhou, Chunyan Ji, Wei Xu, Kaiyang Ding, Li Yu, Zheng Wang, Nawei Liu, Yejiang Lou, Yue Shen, Yi Chen, Fenlai Tan, Jun Zhu
Journal: Blood
Blood (2023) 142 (Supplement 1): 4400.
https://doi.org/10.1182/blood-2023-180485
Published: 2023
Journal Articles

Emicizumab Prophylaxis for the Treatment of Chinese Hemophilia A Patients in the Real World: A Multi-Center Retrospective Analysis

Free
Yuan Xu, Ying Wang, Runhui Wu, Changcheng Zheng, Jianwen Xiao, Weiqun Xu, Xiaoqin Feng, Hua Wang, Xiangshan Cao, Liya He, Tianyang Xue, Mingwei Jin, Bingshou Xie, Jing Ling, Lirong Sun, Rui Su, Hongbo Cheng, Yongjun Fang, Bai Li, Ziqiang Yu, Ailing Xue, Mei Sun, Li Yang, Zeping Zhou, Hu Zhou, Jiao Jin, Min Zhou, Rong Chen, Wei Liu, Lei Zhang, Feng Xue, Renchi Yang
Journal: Blood
Blood (2023) 142 (Supplement 1): 2624.
https://doi.org/10.1182/blood-2023-174698
Published: 2023
Journal Articles

Homoharringtonine-Based Induction Regimens Combined with ATRA-Based Maintenance in Chinese Pediatric AML: A Report from the Cclg-AML 2015 Protocol Study

Free
Jing Li, Ju Gao, Ansheng Liu, Wei Liu, Hao Xiong, Changda Liang, Yongjun Fang, Yunpeng Dai, Jingbo Shao, Hui Yu, Lingzhen Wang, Li Wang, Liangchun Yang, Mei Yan, Xiaowen Zhai, Xiaodong Shi, Xin Tian, Xiuli Ju, Yan Chen, Jing Wang, Leping Zhang, Hui Liang, Sen Chen, Jingrong Zhang, Haixia Cao, Jiao Jin, Qun Hu, Junlan Wang, Yilin Wang, Min Zhou, Yueqin Han, Rong Zhang, Weihong Zhao, Aimin Li, Limin Lin, Ruidong Zhang, Chao Gao, Liting Xu, Yuanyuan Zhang, Jia Fan, Ying Wu, Wei Lin, Jiaole Yu, Peijing Qi, Pengli Huang, Xiaoxia Peng, Yaguang Peng, Huyong Zheng
Journal: Blood
Blood (2022) 140 (Supplement 1): 3189–3191.
https://doi.org/10.1182/blood-2022-165737
Published: 2022
Journal Articles

Intravenous Lentiviral Gene Therapy for Hemophilia a: Endothelial-Specific Expression and Increased Glycosylation for Improved FVIII Function

Free
Jie Gong, Yuchen Liu, Min Zhou, Lung-Ji Chang
Journal: Blood
Blood (2022) 140 (Supplement 1): 10650–10651.
https://doi.org/10.1182/blood-2022-159840
Published: 2022
Journal Articles

Intravenous Lentiviral Gene Therapy for Hemophilia a: In Vitro and In Vivo Assessment of Universal Versus Tissue-Specific Promoters

Free
Jie Gong, Tsai-Hua Chung, Min Zhou, Lung-Ji Chang
Journal: Blood
Blood (2021) 138 (Supplement 1): 2941.
https://doi.org/10.1182/blood-2021-147686
Published: 2021
Journal Articles

Tanshinone Iia Inhibits Megakaryopoiesis in Immune Vasculitis

Free
Hui Chen, Min Zhou, Huiying Shu, Weiqing Su, Liuming Yang, Liang Li, Beng H Chong, Mo Yang
Journal: Blood
Blood (2021) 138 (Supplement 1): 4288.
https://doi.org/10.1182/blood-2021-152162
Published: 2021
Journal Articles

Safety and Efficacy of Mitoxantrone Hydrochloride Liposome in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma and Extranodal NK/T-Cell Lymphoma: A Prospective, Single-Arm, Open-Label, Multi-Center, Phase Ⅱ Clinical Trial

Free
Yan Gao, MD PhD, Huiqiang Huang, MDPhD, Xiaoxiao Wang, Bing Bai, Yunhong Huang, MD PhD, Haiyan Yang, MD PhD, QingYuan Zhang, MD, Yufu Li, Yan Li, Min Zhou, PhD, Runxiang Yang, Bing Xu, Lihong Liu, MD, Yu Yang, MD PhD, Zhigang Peng, Ding Yu, Hui Zhou, MD PhD, Rong yan Zhang, Huilai Zhang, MD PhD, Junyuan Qi, MD, Yaming Xi, Xiaojing Xing, Zhao Wang, MD, Hongmei Jing, Xiaohong Zhang, Liping Ma, Hongyan Jin, Hongxia Yao, PhD, Yuerong Shuang, Xuefang Xia, Jianfei Xue, Chunlei Li
Journal: Blood
Blood (2020) 136 (Supplement 1): 36–37.
https://doi.org/10.1182/blood-2020-141752
Published: 2020
Journal Articles

Safety and Efficacy of Mitoxantrone Hydrochloride Liposome in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma and Extranodal NK/T-Cell Lymphoma: A Multicenter, Single-Arm, Open-Label, Phase 2 Clinical Trial

Free
Hui-qiang Huang, Yunhong Huang, MD PhD, Gao Yan, Haiyan Yang, Qingyuan Zhang, Runxiang Yang, Min Zhou, PhD, Yufu Li, Yan Li, Lihong Liu, Hui Zhou, MD PhD, Hongmei Jing, Zhigang Peng, MD, Ding Yu, Rong yan Zhang, Bing Xu, Xiaohong Zhang, Junyuan Qi, Liping MA, MD, Shan Chen, Jianfei Xue
Journal: Blood
Blood (2019) 134 (Supplement_1): 2838.
https://doi.org/10.1182/blood-2019-126481
Published: 2019